These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 26052098)

  • 1. Aicardi-Goutières syndrome and the type I interferonopathies.
    Crow YJ; Manel N
    Nat Rev Immunol; 2015 Jul; 15(7):429-40. PubMed ID: 26052098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferonopathies: a novel set of inborn errors of immunity.
    Crow YJ
    Ann N Y Acad Sci; 2011 Nov; 1238():91-8. PubMed ID: 22129056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type I interferonopathies].
    Munoz J; Marque M; Dandurand M; Meunier L; Crow YJ; Bessis D
    Ann Dermatol Venereol; 2015 Nov; 142(11):653-63. PubMed ID: 26363997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon in neurological disease-the devil from within.
    Hofer MJ; Campbell IL
    Cytokine Growth Factor Rev; 2013 Jun; 24(3):257-67. PubMed ID: 23548179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferonopathies in pediatric rheumatology.
    Volpi S; Picco P; Caorsi R; Candotti F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):35. PubMed ID: 27260006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferonopathies: From concept to clinical practice.
    Mendonça LO; Frémond ML
    Best Pract Res Clin Rheumatol; 2024 Sep; 38(3):101975. PubMed ID: 39122631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapies in Aicardi-Goutières syndrome.
    Crow YJ; Vanderver A; Orcesi S; Kuijpers TW; Rice GI
    Clin Exp Immunol; 2014 Jan; 175(1):1-8. PubMed ID: 23607857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Type I Interferonopathies.
    Lee-Kirsch MA
    Annu Rev Med; 2017 Jan; 68():297-315. PubMed ID: 27813875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.
    Yu ZX; Song HM
    World J Pediatr; 2020 Feb; 16(1):44-51. PubMed ID: 31377974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dirty Fish Versus Squeaky Clean Mice: Dissecting Interspecies Differences Between Animal Models of Interferonopathy.
    Rutherford HA; Kasher PR; Hamilton N
    Front Immunol; 2020; 11():623650. PubMed ID: 33519829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutieres syndrome.
    Cuadrado E; Jansen MH; Anink J; De Filippis L; Vescovi AL; Watts C; Aronica E; Hol EM; Kuijpers TW
    Brain; 2013 Jan; 136(Pt 1):245-58. PubMed ID: 23365100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-tuning of type I IFN-signaling in microglia--implications for homeostasis, CNS autoimmunity and interferonopathies.
    Goldmann T; Blank T; Prinz M
    Curr Opin Neurobiol; 2016 Feb; 36():38-42. PubMed ID: 26397019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoinflammatory phenotypes in Aicardi-Goutières syndrome with interferon upregulation and serological autoimmune features.
    Sugawara Y; Imai K; Kashimada A; Moriyama K; Baba S; Nishikomori R; Motegi M; Takeuchi Y; Morio T
    J Allergy Clin Immunol; 2018 Mar; 141(3):1135-1138. PubMed ID: 29132962
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracellular Nucleic Acid Detection in Autoimmunity.
    Crowl JT; Gray EE; Pestal K; Volkman HE; Stetson DB
    Annu Rev Immunol; 2017 Apr; 35():313-336. PubMed ID: 28142323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I Interferonopathies: A Clinical Review.
    Wang CS
    Rheum Dis Clin North Am; 2023 Nov; 49(4):741-756. PubMed ID: 37821193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity.
    Behrendt R; Roers A
    Clin Exp Immunol; 2014 Jan; 175(1):9-16. PubMed ID: 23713592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory myopathy in a patient with Aicardi-Goutières syndrome.
    Tumienė B; Voisin N; Preikšaitienė E; Petroška D; Grikinienė J; Samaitienė R; Utkus A; Reymond A; Kučinskas V
    Eur J Med Genet; 2017 Mar; 60(3):154-158. PubMed ID: 28089741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic interferonopathies: An overview.
    Eleftheriou D; Brogan PA
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):441-459. PubMed ID: 29773266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi-Goutières Syndrome, a Type I Interferonopathy.
    Meesilpavikkai K; Dik WA; Schrijver B; van Helden-Meeuwsen CG; Versnel MA; van Hagen PM; Bijlsma EK; Ruivenkamp CAL; Oele MJ; Dalm VASH
    Arthritis Rheumatol; 2019 May; 71(5):829-831. PubMed ID: 30666809
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuromyelitis optica in a child with Aicardi-Goutières syndrome.
    Hacohen Y; Zuberi S; Vincent A; Crow YJ; Cordeiro N
    Neurology; 2015 Jul; 85(4):381-3. PubMed ID: 26136517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.